Dexcom (DXCM) Receivables - Net (2010 - 2026)

Dexcom (DXCM) has 17 years of Receivables - Net data on file, last reported at $1.1 billion in Q1 2026.

• On a quarterly basis, Receivables - Net fell 5.77% year-over-year to $1.1 billion in Q1 2026; TTM through Mar 2026 was $1.1 billion, a 5.77% decrease from a year earlier, with the FY2025 full-year figure at $1.2 billion, up 19.82% from the prior year.
• Receivables - Net for Q1 2026 stood at $1.1 billion, down from $1.2 billion in the prior quarter.
• Over the last five years, Receivables - Net for DXCM reached as high as $1.3 billion in Q2 2025 and fell as low as $544.5 million in Q1 2022.
• Historically, Receivables - Net has averaged $905.2 million across 5 years, with a median of $973.9 million in 2023.
• Across the five-year window, Receivables - Net soared 53.67% in 2024 and declined 5.77% in 2026, its largest moves.
• Year by year, Receivables - Net stood at $713.3 million in 2022, then surged by 36.53% to $973.9 million in 2023, then gained by 4.21% to $1.0 billion in 2024, then climbed by 19.82% to $1.2 billion in 2025, then dropped by 10.48% to $1.1 billion in 2026.
• Per Business Quant data, the three most recent Receivables - Net figures were $1.1 billion in Q1 2026, $1.2 billion in Q4 2025, and $1.1 billion in Q3 2025.